No, the PLO Isn't a Person
Fuld v. PLO marks a turning point in a long legal saga. In 2004 U.S. citizens sued the Palestinian Authority for its role in terror attacks that killed their family members. After a seven-week trial, a New York federal jury found the authority liable.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Young woman shot dead while walking child to bus stop, suspect at large: Police
A young woman was struck and killed by gunfire while walking a child to a bus stop in Louisville, Kentucky, on Wednesday morning, and authorities are now searching for the shooter. The child who was with the woman wasn't physically hurt, Louisville Metro Police Chief Paul Humphrey told reporters. MORE: 4-year-old girl, her grandfather, Target worker killed in 'unprovoked' shooting in Austin: Police A 15-year-old boy was taken into custody earlier in the day in connection with the shooting, but authorities determined he was not a suspect and he's been released, police said. Authorities then released images of a person of interest and said they're asking for the public's help to identify him. "We do have a description of a young black male dressed in a red hoodie and black sweatpants," Humphrey said. The shooting was in front of "very small children," Humphrey said. The children who witnessed the gunfire "are forever impacted by this," Humphrey said, noting that counselors are being provided. MORE: Search underway for man dropped off by ride share in Rocky Mountain National Park This marks the second shooting at a Louisville bus stop within one week. On Aug. 7 -- Jefferson County's first day of school -- multiple shots were fired at a bus stop, police said. No one was hurt and a suspect was arrested, police said. Officers had been positioned at the site of Wednesday's shooting each morning since Aug. 7, Humphrey said, but "today happened to be the first morning that we did not have officers at this bus stop." "Kids should be able to go to school, go to the bus stop in the morning without any fear of gun violence, of having to run for their life in the morning," Humphrey said. "It's absolutely unacceptable that these types of incidents have happened now twice in the last week." ABC News' Michael Pappano contributed to this report.
Yahoo
9 minutes ago
- Yahoo
New York man charged with cyberstalking a family member of slain UnitedHealthcare CEO
ALBANY, N.Y. (AP) — A New York man has been charged with cyberstalking a family member of slain UnitedHealthcare CEO Brian Thompson, allegedly leaving threatening voicemails that expressed glee about the killing within hours of the fatal shooting, federal prosecutors said Wednesday. Shane Daley, 40, is accused of placing multiple calls to Thompson's family member after the shooting, justifying the killing and saying that the person deserved to die in a similar manner, according to a criminal complaint. Daley, of Galway, New York, a small town north of Albany, was scheduled to be arraigned Wednesday afternoon. Information on whether Daley had an attorney was not immediately available in online federal court records. In a statement, Acting United States Attorney John A. Sarcone said that 'Brian Thompson was gunned down in midtown Manhattan. Daley, as alleged, gleefully welcomed this tragedy and did all that he could to increase the Thompson family's pain and suffering." Thompson was fatally shot outside a hotel in New York City in December by a man who prosecutors said was angered over what he viewed as corporate greed. The suspect, Luigi Mangione, has pleaded not guilty. The Associated Press Sign in to access your portfolio
Yahoo
9 minutes ago
- Yahoo
Exclusive-US pharma tariffs likely weeks away as Trump plans for Alaska, sources say
By Maggie Fick, Andrea Shalal and Dave Graham WASHINGTON (Reuters) -The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new sector-specific U.S. tariffs likely remains weeks away, four official and industry sources said, later than initially promised as he focuses on other matters. Commerce Secretary Howard Lutnick had said in April when the review of whether reliance on foreign drug production threatens U.S. national security was launched that he anticipated that it would conclude between mid-May and mid-June. Global pharmaceutical companies are bracing for the outcome of the investigation, which will usher in sector-specific tariffs that Trump has said could start small and eventually rise to 250%. The Republican president said as recently as last week that his plan relies on phased-in tariffs, giving drugmakers time to increase manufacturing in the United States as he pushes to alter what he says are global trade distortions in many industries. One government official in Europe and a source with knowledge of the White House process, as well as two sources at European drug firms familiar with the process, told Reuters that the report and tariffs announcement was not imminent and likely weeks away. These sources spoke on condition of anonymity. A White House spokesperson, asked about media reporting indicating that the results of the probe could be several weeks away, cautioned that such reports were pure speculation unless confirmed by the White House. The spokesperson declined to give further details about the timing of the pharma probe or one involving semiconductors. The investigation is examining pharmaceutical imports ranging from finished prescription drugs to active pharmaceutical ingredients, called APIs, and other raw materials, with the results to be disclosed in a Commerce Department report. Lutnick said last month the tariff plan that will be based on the report would be completed by the end of July. Lutnick then said on July 29 it would be two more weeks. The investigation was launched under Section 232 of the Trade Expansion Act of 1962. While the investigation is ongoing, the pharmaceutical sector has been exempted from the sweeping tariffs imposed by the Trump administration. The United States has reached bilateral trade deals with the UK, Japan, South Korea and the European Union that promised more favorable terms for their pharma exports than those expected to be levied on the sector globally. A European government official said that an announcement before the end of August appears unlikely but cautioned that the timeline could shift depending on other developments. A source at a European drugmaker said the Trump administration is focused on the U.S.-Russia summit in Alaska on Friday and therefore no announcement is expected this week. The source familiar with the White House process said that announcement is unlikely to come this week given other priorities. That source and one other source said that they expect the Trump administration to announce the results of its national security investigation into semiconductors first, followed by the pharma announcement, putting it a few weeks away. The Section 232 provision authorizes the president to adjust imports - including imposing tariffs - if a category of goods is being imported into the United States in quantities that "threaten or impair the national security." Medical goods historically have been spared from trade wars due to the potential harm to patient access, and drugmakers have said tariffs could undercut other health policy goals outlined by the Trump administration, including lowering drug prices. U.S. tariffs on imported pharmaceutical products would mark the latest in a series of sectoral tariffs announced by the administration, following metals and cars, that some economists have predicted will drive up costs for American consumers.
